News

25 August 2021

Viscgo completes £315k investment round

Manchester-based medical device company Viscgo has a completed a £315,000 investment round.

The firm, based in Manchester Science Park, has been able to complete this due to a £50,000 investment from North West early-stage investor GC Angels. 

This comes following funding from a predominantly North West cohort of institutional and private investors including the GM&C Life Sciences Fund, managed by Catapult Ventures, and Deepbridge Capital. 
 
Founded by speech and language therapist Dr Elizabeth Boaden and new product development and engineering specialist Steven Bookbinder, Viscgo’s products improve the management of dysphagia, or swallowing difficulties, for patients, carers, clinicians and dysphagia practitioners. 
 
With the investment round, Viscgo is seeking to establish its reach, enabling it to support a growing clientele of dysphagia patients and carers. As well as investing in research and development, the funding round has been used to recruit business development and marketing managers, growing the team to eight. 
 
Steven Bookbinder, founder and chief executive of Viscgo, said: “This phase of investment has come at a pivotal time as we launch our Drink Thickness Test Sticks and take on new members of the team."
 
Jess Jackson, head of investment at GC Angels, said: "We’re pleased that we were able to finish off this significant investment round, and are looking forward to seeing the outcomes of the team’s work to expand its reach both in Manchester and beyond.” 
 
Daniel Zamora, commercial programme manager at Health Innovation Manchester said: "We are excited to be working with Viscgo and supporting their acceleration by providing access to specialist insights and validating the clinical need for their innovation."

From our portfolio

Manchester Biotech (Manchester Biogel)

Biotechnology

viewview our portfolio

Our Team

Nick Wright

CEO

view complete team

Contact us

Tel: 01625 344300

email